Personalized cancer vaccine: Moderna news leads to market frenzy
Moderna stock just surged 90% after its experimental vaccine for deadliest skin cancer passed a landmark late-stage trial. The mRNA-Keytruda ...
Moderna stock just surged 90% after its experimental vaccine for deadliest skin cancer passed a landmark late-stage trial. The mRNA-Keytruda ...
Scientists diving in the icy waters of Antarctica were stunned to discover a unique bacterium that, over millions of years, ...
New study finds that bacteria residing within tumor cells themselves might boost immunotherapy.
So far the vaccine has been proven effective in mice in preventing the development of melanoma and in treating primary ...
The first issue of Israel Hayom appeared on July 30, 2007. Israel Hayom was founded on the belief that the Israeli public deserves better, more balanced and more accurate journalism. Journalism that speaks, not shouts. Journalism of a different kind. And free of charge.
All rights reserved to Israel Hayom
Hosted by sPD.co.il
[contact-form-7 id=”508379″ html_id=”isrh_form_Newsletter_en” title=”newsletter_subscribe”]